Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.The Serie's long term average value is 1.09 Billion Hong Kong Dollars. It's latest available value, on 03/31/2024, is -1.08 Billion Hong Kong Dollars lower, compared to it's long term average value.
The Serie's change in Hong Kong Dollars from it's minimum value, on 06/30/2012, to it's latest available value, on 03/31/2024, is +0.0856 Billion.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 03/31/2024, is -99.92%.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Deferred Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |